Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
POLYPEPTIDE AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/045510
Kind Code:
A1
Abstract:
The present invention provides a polypeptide. The present invention also provides a nucleic acid for encoding said polypeptide, a nucleic-acid construct, expression vector, and host cell containing said nucleic acid, and the surface of the cell presenting an antigen presenting cell and immune effector cell thereof. The present invention also provides a pharmaceutical composition containing said polypeptide, a vaccine, an antibody, and a treatment method, diagnosis method, and diagnosis apparatus. The present invention also provides an application of the described polypeptide in preparing a vaccine, tumor diagnosis kit, or pharmaceutical composition, and an application of the described polypeptide as a test target in tumor diagnosis.

Inventors:
LUO SHUNTAO (CN)
LIN XIUMEI (CN)
AN TING (CN)
LI BO (CN)
HOU YONG (CN)
Application Number:
PCT/CN2016/098329
Publication Date:
March 15, 2018
Filing Date:
September 07, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GENOIMMUNE THERAPEUTICS CO LTD (CN)
International Classes:
C07K7/06; A61K39/395; A61P35/00; C07K16/00; C12N15/11; C12N15/63
Foreign References:
US20090208538A12009-08-20
CN102618498A2012-08-01
Other References:
FAN, WEIPING ET AL.: "Anti-Tumor Effects of WT1-235 Peptide", IMMUNOLOGICAL JOURNAL, vol. 27, no. 5, 1 May 2011 (2011-05-01)
FAN, WEIPING ET AL.: "Anti-Tumor Effects of WT1-235 Peptide", IMMUNOLOGICAL JOURNAL, vol. 27, no. 5, 1 May 2011 (2011-05-01), pages 377 - 380
LIAO, ZHONGLI ET AL.: "Antitumor Effect of New Multiple Antigen Peptide Based on HLA-A0201-Restrieted CTL Epitopes of Human Telomerase Reverse Transcriptase (hTERT", CANCER SCIENCE, vol. 103, no. 11, 28 September 2012 (2012-09-28)
Attorney, Agent or Firm:
TSINGYIHUA INTELLECTUAL PROPERTY LLC (CN)
Download PDF: